diff test-data/out1.tabular @ 3:c5bb987015c5 draft default tip

Uploaded
author devteam
date Fri, 07 Mar 2014 16:34:26 -0500
parents 8c6dc9da6c89
children
line wrap: on
line diff
--- a/test-data/out1.tabular	Tue Feb 25 14:19:17 2014 -0500
+++ b/test-data/out1.tabular	Fri Mar 07 16:34:26 2014 -0500
@@ -15,30 +15,32 @@
 RET	gene1	RET	ret proto-oncogene	TYROSINE KINASE,DRUGGABLE GENOME,KINASE,CLINICALLY ACTIONABLE	inhibitor	LENVATINIB	TALC
 RET	gene1	RET	ret proto-oncogene	TYROSINE KINASE,DRUGGABLE GENOME,KINASE,CLINICALLY ACTIONABLE	inhibitor	AMUVATINIB	TALC
 RET	gene1	RET	ret proto-oncogene	TYROSINE KINASE,DRUGGABLE GENOME,KINASE,CLINICALLY ACTIONABLE	inhibitor	AT9283	TALC
+RET	gene1	RET	ret proto-oncogene	TYROSINE KINASE,DRUGGABLE GENOME,KINASE,CLINICALLY ACTIONABLE	n/a	VANDETANIB	ClearityFoundationClinicalTrial
+RET	gene1	RET	ret proto-oncogene	TYROSINE KINASE,DRUGGABLE GENOME,KINASE,CLINICALLY ACTIONABLE	n/a	DOVITINIB	ClearityFoundationClinicalTrial
 BIRC3	gene2	BIRC3	baculoviral IAP repeat containing 3		antagonist	AEG40826	TALC
 BIRC3	gene2	BIRC3	baculoviral IAP repeat containing 3		antagonist	TL 32711	TALC
 BIRC3	gene2	BIRC3	baculoviral IAP repeat containing 3		antagonist	AT-406	TALC
 BIRC3	gene2	BIRC3	baculoviral IAP repeat containing 3		antagonist	GDC0917	TALC
 BIRC3	gene2	BIRC3	baculoviral IAP repeat containing 3		antagonist	LCL161	TALC
-ATM	gene3	ATM	ataxia telangiectasia mutated	PHOSPHATIDYLINOSITOL 3 KINASE,DRUGGABLE GENOME,CLINICALLY ACTIONABLE,SERINE THREONINE KINASE,KINASE,TUMOR SUPPRESSOR,DNA REPAIR	n/a	E7449	ClearityFoundation
-ATM	gene3	ATM	ataxia telangiectasia mutated	PHOSPHATIDYLINOSITOL 3 KINASE,DRUGGABLE GENOME,CLINICALLY ACTIONABLE,SERINE THREONINE KINASE,KINASE,TUMOR SUPPRESSOR,DNA REPAIR	n/a	NIRAPARIB	ClearityFoundation
-ATM	gene3	ATM	ataxia telangiectasia mutated	PHOSPHATIDYLINOSITOL 3 KINASE,DRUGGABLE GENOME,CLINICALLY ACTIONABLE,SERINE THREONINE KINASE,KINASE,TUMOR SUPPRESSOR,DNA REPAIR	n/a	OLAPARIB	ClearityFoundation
-ATM	gene3	ATM	ataxia telangiectasia mutated	PHOSPHATIDYLINOSITOL 3 KINASE,DRUGGABLE GENOME,CLINICALLY ACTIONABLE,SERINE THREONINE KINASE,KINASE,TUMOR SUPPRESSOR,DNA REPAIR	n/a	BMN673	ClearityFoundation
-ATM	gene3	ATM	ataxia telangiectasia mutated	PHOSPHATIDYLINOSITOL 3 KINASE,DRUGGABLE GENOME,CLINICALLY ACTIONABLE,SERINE THREONINE KINASE,KINASE,TUMOR SUPPRESSOR,DNA REPAIR	n/a	RUCAPARIB	ClearityFoundation
-ATM	gene3	ATM	ataxia telangiectasia mutated	PHOSPHATIDYLINOSITOL 3 KINASE,DRUGGABLE GENOME,CLINICALLY ACTIONABLE,SERINE THREONINE KINASE,KINASE,TUMOR SUPPRESSOR,DNA REPAIR	n/a	VELIPARIB	ClearityFoundation
-KRAS	gene4	KRAS	v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog	CLINICALLY ACTIONABLE	n/a	VANDETANIB	ClearityFoundation
-KRAS	gene4	KRAS	v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog	CLINICALLY ACTIONABLE	n/a	EVEROLIMUS	ClearityFoundation
-KRAS	gene4	KRAS	v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog	CLINICALLY ACTIONABLE	n/a	TEMSIROLIMUS	ClearityFoundation
-KRAS	gene4	KRAS	v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog	CLINICALLY ACTIONABLE	n/a	GDC-0973	ClearityFoundation
-KRAS	gene4	KRAS	v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog	CLINICALLY ACTIONABLE	n/a	MEK162	ClearityFoundation
-KRAS	gene4	KRAS	v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog	CLINICALLY ACTIONABLE	n/a	PD-325901	ClearityFoundation
-KRAS	gene4	KRAS	v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog	CLINICALLY ACTIONABLE	n/a	RAFAMETINIB	ClearityFoundation
-KRAS	gene4	KRAS	v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog	CLINICALLY ACTIONABLE	n/a	SELUMETINIB	ClearityFoundation
-KRAS	gene4	KRAS	v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog	CLINICALLY ACTIONABLE	n/a	TRAMETINIB	ClearityFoundation
-KRAS	gene4	KRAS	v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog	CLINICALLY ACTIONABLE	n/a	CETUXIMAB	ClearityFoundation
-KRAS	gene4	KRAS	v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog	CLINICALLY ACTIONABLE	n/a	ERLOTINIB	ClearityFoundation
-KRAS	gene4	KRAS	v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog	CLINICALLY ACTIONABLE	n/a	GEFITINIB	ClearityFoundation
-KRAS	gene4	KRAS	v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog	CLINICALLY ACTIONABLE	n/a	PANITUMUMAB	ClearityFoundation
-KRAS	gene4	KRAS	v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog	CLINICALLY ACTIONABLE	n/a	PIMASERTIB	ClearityFoundation
+ATM	gene3	ATM	ataxia telangiectasia mutated	PHOSPHATIDYLINOSITOL 3 KINASE,DRUGGABLE GENOME,CLINICALLY ACTIONABLE,SERINE THREONINE KINASE,KINASE,TUMOR SUPPRESSOR,DNA REPAIR	n/a	E7449	ClearityFoundationBiomarkers
+ATM	gene3	ATM	ataxia telangiectasia mutated	PHOSPHATIDYLINOSITOL 3 KINASE,DRUGGABLE GENOME,CLINICALLY ACTIONABLE,SERINE THREONINE KINASE,KINASE,TUMOR SUPPRESSOR,DNA REPAIR	n/a	NIRAPARIB	ClearityFoundationBiomarkers
+ATM	gene3	ATM	ataxia telangiectasia mutated	PHOSPHATIDYLINOSITOL 3 KINASE,DRUGGABLE GENOME,CLINICALLY ACTIONABLE,SERINE THREONINE KINASE,KINASE,TUMOR SUPPRESSOR,DNA REPAIR	n/a	OLAPARIB	ClearityFoundationBiomarkers
+ATM	gene3	ATM	ataxia telangiectasia mutated	PHOSPHATIDYLINOSITOL 3 KINASE,DRUGGABLE GENOME,CLINICALLY ACTIONABLE,SERINE THREONINE KINASE,KINASE,TUMOR SUPPRESSOR,DNA REPAIR	n/a	BMN673	ClearityFoundationBiomarkers
+ATM	gene3	ATM	ataxia telangiectasia mutated	PHOSPHATIDYLINOSITOL 3 KINASE,DRUGGABLE GENOME,CLINICALLY ACTIONABLE,SERINE THREONINE KINASE,KINASE,TUMOR SUPPRESSOR,DNA REPAIR	n/a	RUCAPARIB	ClearityFoundationBiomarkers
+ATM	gene3	ATM	ataxia telangiectasia mutated	PHOSPHATIDYLINOSITOL 3 KINASE,DRUGGABLE GENOME,CLINICALLY ACTIONABLE,SERINE THREONINE KINASE,KINASE,TUMOR SUPPRESSOR,DNA REPAIR	n/a	VELIPARIB	ClearityFoundationBiomarkers
+KRAS	gene4	KRAS	v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog	CLINICALLY ACTIONABLE	n/a	VANDETANIB	ClearityFoundationBiomarkers
+KRAS	gene4	KRAS	v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog	CLINICALLY ACTIONABLE	n/a	EVEROLIMUS	ClearityFoundationBiomarkers
+KRAS	gene4	KRAS	v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog	CLINICALLY ACTIONABLE	n/a	TEMSIROLIMUS	ClearityFoundationBiomarkers
+KRAS	gene4	KRAS	v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog	CLINICALLY ACTIONABLE	n/a	GDC-0973	ClearityFoundationBiomarkers
+KRAS	gene4	KRAS	v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog	CLINICALLY ACTIONABLE	n/a	MEK162	ClearityFoundationBiomarkers
+KRAS	gene4	KRAS	v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog	CLINICALLY ACTIONABLE	n/a	PD-325901	ClearityFoundationBiomarkers
+KRAS	gene4	KRAS	v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog	CLINICALLY ACTIONABLE	n/a	RAFAMETINIB	ClearityFoundationBiomarkers
+KRAS	gene4	KRAS	v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog	CLINICALLY ACTIONABLE	n/a	SELUMETINIB	ClearityFoundationBiomarkers
+KRAS	gene4	KRAS	v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog	CLINICALLY ACTIONABLE	n/a	TRAMETINIB	ClearityFoundationBiomarkers
+KRAS	gene4	KRAS	v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog	CLINICALLY ACTIONABLE	n/a	CETUXIMAB	ClearityFoundationBiomarkers
+KRAS	gene4	KRAS	v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog	CLINICALLY ACTIONABLE	n/a	ERLOTINIB	ClearityFoundationBiomarkers
+KRAS	gene4	KRAS	v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog	CLINICALLY ACTIONABLE	n/a	GEFITINIB	ClearityFoundationBiomarkers
+KRAS	gene4	KRAS	v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog	CLINICALLY ACTIONABLE	n/a	PANITUMUMAB	ClearityFoundationBiomarkers
+KRAS	gene4	KRAS	v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog	CLINICALLY ACTIONABLE	n/a	PIMASERTIB	ClearityFoundationBiomarkers
 KRAS	gene4	KRAS	v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog	CLINICALLY ACTIONABLE	inhibitor	REOLYSIN	CancerCommons
 KRAS	gene4	KRAS	v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog	CLINICALLY ACTIONABLE	vaccine	RAS PEPTIDE CANCER VACCINE	TALC